drugset / Trial / NCT00034801

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

NCT00034801

Phase 4 Completed 378 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a research study comparing the safety and efficacy of two active study medications

Timeline

Start
2001-09
Primary completion
Completion
2003-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule
Subject Ziprasidone Small molecule